After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If finalized as proposed, FDA would ...
You’ve just finished a clinic visit with your primary care provider, and you’ve been sent to the lab for a blood test. What happens next?
AVTR stock gains after expanding U.S. lab capabilities, boosting biopharma support, streamlining testing and strengthening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results